Navigation Links
Gemcitabine with Capecitabine effective against pancreatic cancer

Combination of two chemotherapy drugs has found to be effective in treating patients with pancreatic cancer compared to use of single drug. A combination of Gemcitabine and Capecitabine has been found to decrease the number of deaths due to pancreatic cancer.// Early and effective to pancreatic cancer is very important as Pancreatic cancer is one of the most serious of all cancers. It develops when malignant cells form in tissues of your pancreas. Pancreatic cancer is the fourth leading cause of all cancer deaths. That's because pancreatic cancer spreads rapidly and is seldom detected in its early stages.

This clinical trial, which is called the GEMCAP trial, was conducted in England between May 2003 and January 2005 involving 533 patients with, advanced pancreatic cancer. The patients were given either Gemcitabine (Gemzar) alone or Gemcitabine plus capecitabine (Xeloda) and the results was found that patients receiving a combination of both the drugs had increased survival rates of 6 months compared to Gemcitabine group alone. The one-year survival rates for Gemcitabine and capecitabine was 26% compared to only 19% with Gemcitabine alone.

Experts View:

Professor David Cunningham, Institute of Cancer Research at the Royal Marsden Hospital London and lead investigator of the trial said,
'"/>




Page: 1

Related medicine news :

1. Morning after pill effective up to five days after having unprotected sex
2. Distraction therapy found very effective in postoperative patients
3. TELITHROMYCIN - the proven effective new drug for cap
4. Digital mammography proves effective
5. Treatment for pre-menstrual syndrome is ineffective
6. Cost-effective antibiotics for sinusitis treatment
7. An effective way to treat angina
8. Fluoride proves effective against fractures
9. Meningitis C vaccine a cost-effective success
10. An effective drug for lung cancer
11. Naltrexone effective for drinking problems
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... ... management in hospitals, today announced it has completed a round of funding to ... LLC and its partners. Black Granite Capital is a growth equity firm focused ...
(Date:4/26/2017)... ... ... Journal of Oral Implantology – Tooth loss is not simply an ... complications with speech, eating, and overcompensation of mouth due to the deficiency. To combat ... number of tooth replacements increase, it is imperative to design an implant that will ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet ... adoption of e-prescribing as measured in Part D Medicare data. The dataset, called ... pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") data ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology: